ABSTRACT
Self-harm of the skin is a complex problem encountered mainly in adolescents and young adults. The aim of the study was to assess the prevalence of deliberate cutaneous self-harm without suicidal intent among secondary school teenagers of the Lodz region. A self-administered specially designed anonymous questionnaire was delivered to 1,448 secondary school teenagers, aged 12-19 years. The lifetime prevalence of self-reported deliberate self-harm was 19.5%, out of which 14.4% confirmed isolated cutaneous self-injury (self-cutting in the vast majority of cases), 1.7% ingested a substance or drug in excessive amounts and 3.5% declared both behaviours. Our results indicate that skin is the organ most commonly involved in deliberate self-harm. Dermatologists, especially those focussed on dermatosurgery and aesthetic dermatology, should understand the special issues relating to such patients before taking decisions concerning performing any procedures on these individuals, since deliberate self-harm has been recognised as one of the main risk factors of suicide.
Subject(s)
Adolescent Behavior , Health Behavior , Self-Injurious Behavior/epidemiology , Skin/injuries , Adolescent , Age Factors , Child , Female , Health Knowledge, Attitudes, Practice , Humans , Male , Poland/epidemiology , Prevalence , Risk Factors , Self-Injurious Behavior/diagnosis , Self-Injurious Behavior/psychology , Surveys and Questionnaires , Young AdultABSTRACT
The authors presents the state of knowledge on the prevalence and proposed mechanisms leading to weight gain during treatment with atypical antipsychotics. A short review on the therapeutic approaches is also supplied.
Subject(s)
Antipsychotic Agents/adverse effects , Body Weight/drug effects , Weight Gain/drug effects , Clozapine/adverse effects , Dibenzothiazepines/adverse effects , Humans , Hyperlipidemias/chemically induced , Leptin/metabolism , Piperazines/adverse effects , Psychotic Disorders/drug therapy , Quetiapine Fumarate , Risperidone/adverse effects , Thiazoles/adverse effectsABSTRACT
The functioning of Hypothalamic-Pituitary-Gonadal axis is commonly affected during a course of antipsychotic therapy. This paper presents epidemiology, possible cause and management of hormonal disturbances during antipsychotic treatment in patients with schizophrenia.
